Esprinet Statistics

Total Valuation

Esprinet has a market cap or net worth of GBP 182.14 million. The enterprise value is 482.03 million.

Market Cap	182.14M
Enterprise Value	482.03M

Important Dates

The next estimated earnings date is Tuesday, March 11, 2025.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.22%
Shares Change (QoQ)	+3.68%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	27.84M

Valuation Ratios

The trailing PE ratio is 11.15.

PE Ratio	11.15
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.95, with an EV/FCF ratio of -16.54.

EV / Earnings	29.52
EV / Sales	0.14
EV / EBITDA	8.95
EV / EBIT	13.88
EV / FCF	-16.54

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 1.22.

Current Ratio	1.25
Quick Ratio	0.58
Debt / Equity	1.22
Debt / EBITDA	7.17
Debt / FCF	-13.03
Interest Coverage	1.96

Financial Efficiency

Return on equity (ROE) is 5.38% and return on invested capital (ROIC) is 3.27%.

Return on Equity (ROE)	5.38%
Return on Assets (ROA)	1.51%
Return on Capital (ROIC)	3.27%
Revenue Per Employee	1.86M
Profits Per Employee	9,072
Employee Count	1,776
Asset Turnover	2.37
Inventory Turnover	5.87

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.93% in the last 52 weeks. The beta is 1.35, so Esprinet's price volatility has been higher than the market average.

Beta (5Y)	1.35
52-Week Price Change	-16.93%
50-Day Moving Average	5.14
200-Day Moving Average	5.03
Relative Strength Index (RSI)	37.42
Average Volume (20 Days)	445

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Esprinet had revenue of GBP 3.35 billion and earned 16.33 million in profits. Earnings per share was 0.33.

Revenue	3.35B
Gross Profit	181.24M
Operating Income	34.17M
Pretax Income	20.32M
Net Income	16.33M
EBITDA	41.89M
EBIT	34.17M
Earnings Per Share (EPS)	0.33

Full Income Statement

Balance Sheet

The company has 84.84 million in cash and 379.92 million in debt, giving a net cash position of -295.08 million.

Cash & Cash Equivalents	84.84M
Total Debt	379.92M
Net Cash	-295.08M
Net Cash Per Share	n/a
Equity (Book Value)	311.34M
Book Value Per Share	6.51
Working Capital	238.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.99 million and capital expenditures -6.16 million, giving a free cash flow of -29.15 million.

Operating Cash Flow	-22.99M
Capital Expenditures	-6.16M
Free Cash Flow	-29.15M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 5.42%, with operating and profit margins of 1.02% and 0.49%.

Gross Margin	5.42%
Operating Margin	1.02%
Pretax Margin	0.61%
Profit Margin	0.49%
EBITDA Margin	1.25%
EBIT Margin	1.02%
FCF Margin	n/a

Dividends & Yields

Esprinet does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.22%
Shareholder Yield	-1.22%
Earnings Yield	8.97%
FCF Yield	-16.00%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Esprinet has an Altman Z-Score of 2.66. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.66
Piotroski F-Score	n/a